Important Information Regarding BLENREP (belantamab mafodotin-blmf)

 

View Prescribing Information including Boxed Warning

If you have questions, contact us at 1-877-768-0092

Trademarks are owned by or licensed to the GSK group of companies.

©2022 GSK or licensor.

BLMWCNT220031 November 2022

Produced in USA.